- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Nectar Lifesciences Limited — Updates, 16-09-2025: General Updates
16-09-2025 | 05:07 pm
16-09-2025 | 05:07 pm
Nectar Lifesciences extended the completion of its API and formulations business Slump Sale to Ceph Lifesciences. The deal is now expected to close by late October, an operational update on a key divestment.
No comments yet. Be the first to comment!